Starboard has approached two former Pfizer executives, Ian Read and Frank D’Amelio, to assist in its efforts, and they have ...

As drug companies fret over their finances, they are increasingly partnering with universities to help with early-stage ...

SAN DIEGO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery ...

Marinus Pharmaceuticals (NASDAQ: MRNS) is a micro-cap pharmaceutical stock with multiple Wall Street analysts seeing ...

Bank of America Securities analyst Tazeen Ahmad has maintained their bullish stance on ALNY stock, giving a Buy rating on September 19. Tazeen ...

INGELHEIM, Germany & SOUTH SAN FRANCISCO, Calif., October 09, 2024--Boehringer Ingelheim and Circle Pharma (Circle) announce a new research collaboration and license agreement with the shared goal to ...

CVS Health announced Tuesday it plans to lay off 2,900 employees, a move that comes about a year after the pharmacy chain ...

In a report released yesterday, Whitney Ijem from Canaccord Genuity maintained a Buy rating on Alnylam Pharma (ALNY – Research Report), ...

The Federal Trade Commission staff is criticizing pharmaceutical benefit managers, which negotiate drug discounts. But ...

On Monday, BridgeBio Pharma Inc (BBIO) stock saw a modest uptick, ending the day at $25.46 which represents a slight increase of $0.52 or 2.09% from the prior close of $24.94. The stock opened at $24.

Vertex Pharmaceuticals Incorporated (VRTX) stock saw a modest uptick, ending the day at $455.31 which represents a slight increase of $1.76 or 0.39% from the prior close of $453.55. The stock opened ...

The firm set a price target for Lumos Pharma at $16.00, reflecting an optimistic view of ... This trend supports analysts' anticipation of a sales decline in the current year, as noted in the ...